Kirsten Fleischmann, MPH, MD

Cardiologist

Dr. Kirsten Fleischmann is a cardiologist specializing in echocardiography and non-invasive cardiology. In addition, her research looks at the relationship between noninvasive testing in cardiology and its outcome, the development and evaluation of efficient diagnostic and treatment strategies in acute ischemic syndromes, and the effect of secondhand smoke on outcomes in cardiac disease such as heart failure and acute ischemic syndromes.

Fleischmann earned her medical degree from Washington University School of Medicine in St. Louis, Mo. She went on to receive a masters in public health from Harvard School of Public Health in Boston, Mass. Fleischmann came to UCSF in 1998, where she is a professor and an attending physician.

Clinics

Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Kirsten Fleischmann

Additional Languages

German

Education

Washington University School of Medicine 1986

Residencies

Barnes Hospital, Internal Medicine 1989

Fellowships

Brigham and Women's Hospital, Cardiology 1993

Selected Research and Publications

  1. Sha SJ, Miller ZA, Min SW, Zhou Y, Brown J, Mitic LL, Karydas A, Koestler M, Tsai R, Corbetta-Rastelli C, Lin S, Hare E, Fields S, Fleischmann KE, Powers R, Fitch R, Martens LH, Shamloo M, Fagan AM, Farese RV, Pearlman R, Seeley W, Miller BL, Gan L, Boxer AL. An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations. Alzheimers Dement (N Y). 2017 Nov; 3(4):507-512.
  2. Lee JS, Gonzales R, Vittinghoff E, Corbett KK, Fleischmann KE, Sehgal N, Auerbach AD. Appropriate Reconciliation of Cardiovascular Medications After Elective Surgery and Postdischarge Acute Hospital and Ambulatory Visits. J Hosp Med. 2017 Sep; 12(9):723-730.
  3. Ferket BS, Hunink MG, Khanji M, Agarwal I, Fleischmann KE, Petersen SE. Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease. Heart. 2017 04; 103(7):483-491.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.